{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:15:47Z","timestamp":1793531747189,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5P30 DA013429-25"],"award-info":[{"award-number":["5P30 DA013429-25"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpet.2025.103397","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T11:53:26Z","timestamp":1738756406000},"page":"103397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antagonism of the antinociceptive effects of fentanyl and the veterinary anesthetic xylazine in mice"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2543-7855","authenticated-orcid":false,"given":"Kerim","family":"Cakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumar","family":"Etkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Enrique","family":"Vivas Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-7896","authenticated-orcid":false,"given":"Ellen A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103397_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/acschemneuro.6b00426","article-title":"Neuroprotective effects of a structurally new family of high affinity imidazoline I2 receptor ligands","volume":"8","author":"Ab\u00e1s","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jpet.2025.103397_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2024.100155","article-title":"Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism","volume":"11","author":"Bedard","year":"2024","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.jpet.2025.103397_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000324537","article-title":"Study of adrenergic, imidazoline, and endothelin receptors in clonidine-, morphine-, and oxycodone-induced changes in rat body temperature","volume":"87","author":"Bhalla","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpet.2025.103397_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0028-3908(99)00151-3","article-title":"Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex","volume":"39","author":"Brackett","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103397_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1476-5381.1982.tb09322.x","article-title":"Interactions of drugs active at opiate receptors and drugs active at alpha 2-receptors on various test systems","volume":"77","author":"Browning","year":"1982","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib6","first-page":"808.3","article-title":"Combinations of haloperidol and morphine produce maximal levels of anti-hyperalgesic or potentiation effects in rats with neuropathic pain","volume":"33","author":"Caridad Mena-Valdes","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jpet.2025.103397_bib7","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0014-2999(93)90650-7","article-title":"Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system","volume":"250","author":"Chien","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-3565(25)24045-9","article-title":"Selective antagonism of opioid analgesia by a sigma system","volume":"271","author":"Chien","year":"1994","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(95)00552-8","article-title":"(\u2212)-Pentazocine analgesia in mice: interactions with a sigma receptor system","volume":"294","author":"Chien","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41386-023-01782-2","article-title":"Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model","volume":"49","author":"Choi","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2025.103397_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002508-200305000-00005","article-title":"Sex differences in opioid analgesia: \"from mouse to man\"","volume":"19","author":"Craft","year":"2003","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpet.2025.103397_bib12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7326\/M23-2001","article-title":"Xylazine adulteration of the heroin-fentanyl drug supply : a narrative review","volume":"176","author":"D'Orazio","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpet.2025.103397_bib13","first-page":"113","article-title":"Idazoxan: a novel pharmacological tool for the study of alpha 2-adrenoceptors","volume":"17","author":"Dabir\u00e9","year":"1986","journal-title":"J\u00a0Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuint.2017.02.003","article-title":"Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia","volume":"105","author":"Dalwadi","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jpet.2025.103397_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00506193","article-title":"Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine","volume":"325","author":"Doxey","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FBP.0b013e328348ed08","article-title":"Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice","volume":"22","author":"Dykstra","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/adb.12003","article-title":"Opioid sensitivity in mice selectively bred to consume or not consume methamphetamine","volume":"19","author":"Eastwood","year":"2014","journal-title":"Addict Biol"},{"key":"10.1016\/j.jpet.2025.103397_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103397_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0306-4522(95)00053-L","article-title":"Enhancement of morphine analgesia by the alpha 2-adrenergic antagonist yohimbine","volume":"66","author":"Gear","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpet.2025.103397_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/bja\/76.4.544","article-title":"Antinociceptive actions of intrathecal xylazine: interactions with spinal cord opioid pathways","volume":"76","author":"Goodchild","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpet.2025.103397_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine\u2014a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene","year":"1988","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1749-6632.1995.tb32387.x","article-title":"Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors","volume":"763","author":"Hieble","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpet.2025.103397_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejphar.2013.10.003","article-title":"Identification and characterization of platelet \u03b12-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses","volume":"720","author":"Hikasa","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.euroneuro.2016.10.007","article-title":"Sedative effect of Clozapine is a function of 5-HT2A and environmental novelty","volume":"27","author":"Joshi","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01308-6","article-title":"alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs","volume":"462","author":"Kalkman","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1742-7843.2008.00289.x","article-title":"Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice","volume":"103","author":"Kambur","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jpet.2025.103397_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1037\/pha0000670","article-title":"Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats","volume":"32","author":"Khatri","year":"2024","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1080\/00207450902984002","article-title":"Rotarod impairment: catalepsy-like screening test for antipsychotic side effects","volume":"119","author":"Kirschbaum","year":"2009","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jpet.2025.103397_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jvp.12724","article-title":"The \u03b12A -adrenoceptor subtype plays a key role in the analgesic and sedative effects of xylazine","volume":"42","author":"Kitano","year":"2019","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpet.2025.103397_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pharmthera.2017.03.009","article-title":"Imidazoline I2 receptors: an update","volume":"178","author":"Li","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2011.02.038","article-title":"Imidazoline I2 receptors: target for new analgesics?","volume":"658","author":"Li","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/bja\/aen320","article-title":"Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia","volume":"102","author":"Lin","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpet.2025.103397_bib34","doi-asserted-by":"crossref","first-page":"91099","DOI":"10.18632\/oncotarget.19556","article-title":"Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma","volume":"8","author":"Longhitano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpet.2025.103397_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2005.04.006","article-title":"Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain","volume":"516","author":"MacInnes","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib36","first-page":"62","article-title":"History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia","volume":"22","author":"Madras","year":"2013","journal-title":"J\u00a0Hist Neurosci"},{"key":"10.1016\/j.jpet.2025.103397_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(00)00430-1","article-title":"Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions","volume":"401","author":"Matsumoto","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(91)90468-6","article-title":"Sympatholytic action of yohimbine mediated by 5-HT1A receptors","volume":"199","author":"McCall","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000542-199409000-00022","article-title":"Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats","volume":"81","author":"Meert","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpet.2025.103397_bib40","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.107.121137","article-title":"Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study","volume":"322","author":"Mei","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173825","article-title":"Haloperidol potentiates antinociceptive effects of morphine and disrupt opioid tolerance","volume":"893","author":"Mena-Vald\u00e9s","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3959(85)90176-9","article-title":"Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat","volume":"22","author":"Milne","year":"1985","journal-title":"Pain"},{"key":"10.1016\/j.jpet.2025.103397_bib43","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/bjp.2008.353","article-title":"Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance","volume":"155","author":"Milne","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0149-7634(00)00015-4","article-title":"Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype","volume":"24","author":"Mogil","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jpet.2025.103397_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2012.04.042","article-title":"Temperature-dependent enhancement of the antinociceptive effects of opioids in combination with gabapentin in mice","volume":"686","author":"Neelakantan","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.devbrainres.2005.06.001","article-title":"Effects of opioid receptor and alpha2-adrenoceptor agonists on slow ventral root potentials and on capsaicin and formalin tests in neonatal rats","volume":"158","author":"Otsuguro","year":"2005","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.jpet.2025.103397_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(94)00695-4","article-title":"Differential cross-tolerance between analgesia produced by alpha 2-adrenoceptor agonists and receptor subtype selective opioid treatments","volume":"272","author":"Paul","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib48","article-title":"The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants and antipsychotics for the human \u03b12A, \u03b12B, and \u03b12C-adrenoceptors and comparison with human \u03b11 and \u03b2-adrenoceptors","volume":"10","author":"Proudman","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jpet.2025.103397_bib49","first-page":"519","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J\u00a0Urban Health"},{"key":"10.1016\/j.jpet.2025.103397_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2009.02.019","article-title":"Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine","volume":"608","author":"Romero","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2013.02.030","article-title":"Xylazine induced central antinociception mediated by endogenous opioids and \u03bc-opioid receptor, but not \u03b4-or \u03ba-opioid receptors","volume":"1506","author":"Romero","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.jpet.2025.103397_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jpet.2025.103397_bib53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0028-3908(74)90113-0","article-title":"Antagonism of the antinociceptive action of xylazine, an alpha-sympathomimetic agent, by adrenoceptor and cholinoceptor blocking agents","volume":"13","author":"Schmitt","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103397_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1467-2987.2004.00154.x","article-title":"Sedative, analgesic and cardiorespiratory effects of romifidine in cats","volume":"31","author":"Selmi","year":"2004","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.jpet.2025.103397_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bcp.2018.01.032","article-title":"The imidazoline I2 receptor agonist 2-BFI attenuates hypersensitivity and spinal neuroinflammation in a rat model of neuropathic pain","volume":"153","author":"Siemian","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1280289","article-title":"\u201cTranq-dope\u201d overdose and mortality: lethality induced by fentanyl and xylazine","volume":"14","author":"Smith","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111282","article-title":"Xylazine does not enhance fentanyl reinforcement in rats: a behavioral economic analysis","volume":"258","author":"St Onge","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103397_bib58","first-page":"1215","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpet.2025.103397_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3565(25)24246-X","article-title":"Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies","volume":"244","author":"Stevens","year":"1988","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1258\/la.2008.008020","article-title":"Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical procedures","volume":"43","author":"Stokes","year":"2009","journal-title":"Lab Anim"},{"key":"10.1016\/j.jpet.2025.103397_bib61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejphar.2017.09.018","article-title":"Antinociception induced by a novel \u03b12A adrenergic receptor agonist in rodents acute and chronic pain models","volume":"815","author":"Sudo","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib62","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00213-017-4599-4","article-title":"Tolerance and cross-tolerance to the antinociceptive effects of oxycodone and the imidazoline I2 receptor agonist phenyzoline in adult male rats","volume":"234","author":"Thorn","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpet.2025.103397_bib63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.jpet.2025.103397_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropharm.2019.03.023","article-title":"Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances","volume":"151","author":"Varshneya","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103397_bib65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/ph4020233","article-title":"Pharmacological evaluation of 3-carbomethoxy fentanyl in mice","volume":"4","author":"Vuckovic","year":"2011","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpet.2025.103397_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.121.000689","article-title":"Antinociceptive and discriminative stimulus effects of six novel psychoactive opioid substances in male rats","volume":"379","author":"Walker","year":"2021","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib67","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-3565(25)23869-1","article-title":"In\u00a0vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats","volume":"271","author":"Walker","year":"1994","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103397_bib68","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1053\/j.jvca.2016.03.127","article-title":"Effect of oxycodone combined with dexmedetomidine for intravenous patient-controlled analgesia after video-assisted thoracoscopic lobectomy","volume":"30","author":"Wang","year":"2016","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jpet.2025.103397_bib69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(99)00900-0","article-title":"Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments","volume":"389","author":"Ware","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103397_bib70","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2460\/ajvr.74.3.395","article-title":"Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets","volume":"74","author":"Yokota","year":"2013","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jpet.2025.103397_bib71","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1248\/bpb.b15-00183","article-title":"Clonidine reduces nociceptive responses in mouse orofacial formalin model: potentiation by sigma-1 receptor antagonist BD1047 without impaired motor coordination","volume":"38","author":"Yoon","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jpet.2025.103397_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2015.09.008","article-title":"Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1 mg\/kg","volume":"606","author":"Zaretsky","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpet.2025.103397_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113658","article-title":"Bifunctional \u03bc opioid and \u03c31 receptor ligands as novel analgesics with reduced side effects","volume":"223","author":"Zhuang","year":"2021","journal-title":"Eur J Med Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525396102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525396102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:31:00Z","timestamp":1762209060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525396102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022356525396102"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103397","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of the antinociceptive effects of fentanyl and the veterinary anesthetic xylazine in mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103397"}}